AHL Interviews Jay Lichter, Bringing NewCos to San Diego
Synthorx: Synthetic Biology for Better Medicine
COI Can: World Cancer Day
What Makes A Successful Biotech Company?
In the news: Fortis sets out to treat late-stage prostate cancer
Jay Lichter Shares Words of Advice in San Diego Business Journal: What to Avoid When Pitching Investors
Courage in Innovation: COI’s President and CEO, Jay Lichter, Named to PharmaVOICE 100
UT San Diego: Avalon, GSK Form 8th San Diego Biotech
PharmaVOICE: 15 Year Reflections and Predictions
BioSpace: Top 20 Life Science Startups to Watch in the U.S.
BioCentury Explores Early-Stage Investing in “Formative Years”
San Diego Magazine Features Jay Lichter in an Article on San Diego VCs